|
Anxiety and Vagal Control of the Heart in Coronary Disease Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Anxiety and Vagal Control of the Heart in Coronary Disease conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Anxiety and Vagal Control of the Heart in Coronary Disease Clinical research trials and Anxiety and Vagal Control of the Heart in Coronary Disease medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Anxiety and Vagal Control of the Heart in Coronary Disease. Anxiety and Vagal Control of the Heart in Coronary Disease Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Anxiety and Vagal Control of the Heart in Coronary Disease clinical trial. Participants frequently get the best healthcare available for their Anxiety and Vagal Control of the Heart in Coronary Disease condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Anxiety and Vagal Control of the Heart in Coronary Disease  Anxiety and Vagal Control of the Heart in Coronary Disease
Anxiety and Vagal Control of the Heart in Coronary Disease
For Condition: Depression,Heart Diseases,Arrhythmia,Coronary Disease,Cardiovascular Diseases,Death, Sudden, Cardiac
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To examine the role of reduced vagal control of heart rate in the increased risk of cardiac mortality associated with anxiety in a population with established coronary artery disease (CAD). A second objective is to determine whether the effects of anxiety are independent of the effects of depression.
Details: BACKGROUND: Coronary heart disease continues to be the leading cause of death in the United States, despite risk factor reduction and technological advances in treatment options. Prospective studies implicate chronic anxiety as an independent risk factor for fatal coronary heart disease. In particular, anxiety increases the risk of sudden cardiac death substantially. DESIGN NARRATIVE: Nine hundred and fifty CAD patients were recruited for this study from patients hospitalized for elective cardiac catheterization. Anxiety is measured by the Hospital Anxiety Scale, the Spielberger Trait Anxiety Inventory, and the Crown-Crisp Phobic Anxiety Scale. Symptoms of depression are measured by the Montgomery-Asberg Depression Rating Scale, the Hospital Depression Scale, and the Beck Depression Inventory. Vagal control of heart rate is determined using power spectral analysis to measure two indices of vagal control: baroreceptor-mediated vagal reflex cardiac control, and respiratory sinus arrhythmia. Patients are followed at 6 months, l year, 2 years, and 3 years postcatheterization, and cardiac mortality data are obtained, including non-sudden and sudden cardiac death. The data generated by this study are used to examine the involvement of impaired vagal cardiac control in the risk of fatal coronary heart disease and sudden cardiac death associated with anxiety. Specifically, the proposed study examines: (1) the relationship between anxiety and cardiac mortality; (2) the relationship between anxiety and vagal control; (3) the role played by reduced vagal control in mediating anxiety-related risk; and (4) the relationship between depression, vagal control and cardiac risk. Findings of a relationship between anxiety, reduced vagal control and sudden cardiac death would suggest the potential importance of early intervention in cardiac patients with anxiety disorders and would underscore the benefit of aggressive monitoring of arrhythmias in this population, which may ultimately translate to reduced mortality rates.
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
LanaWatkins, , Duke University
Additional Information:
Study ID Numbers: 919;
Study Start Date: June 1999
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006311
Other Heart Diseases Studies:
1. Epidemiology of Coronary Artery Calcification
2. Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
3. Thrombolysis in Myocardial Infarction (TIMI)
4. Sleep Heart Health Study (SHHS)
5. Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables
Related Studies:
Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Anxiety and Vagal Control of the Heart in Coronary Disease
|
|
|
|
|
|
|
|
